Author:
Shramko V. S.,Shcherbakova L. V.,Kashtanova E. V.,Stakhneva E. M.,Polonskaya Ya. V.,Ragino Yu. I.
Publisher
Springer Science and Business Media LLC
Subject
General Biochemistry, Genetics and Molecular Biology,General Medicine
Reference14 articles.
1. Paschos P, Paletas K. Non-alcoholic fatty liver disease and metabolic syndrome. Hippokratia. 2009;13(1):9-19.
2. 2020 Clinical Practice Guidelines for Stable Coronary Artery Disease. Ross. Kardiol. Zh. 2020;25(11):201-250. Russian. doi: https://doi.org/10.15829/1560-4071-2020-4076
3. Velkov VV. Free fatty acids are a new marker of insulin resistance and ischemia. Dalnevostoch. Med. Zh. 2008;(4):120-122. Russian.
4. Zvenigorodskaya LA, Mkrtumyan AM, Shinkin MV, Nilova TV, Silverstova SYu, Varvanina GG, Petrakov AV. Clinical significance of key components adipo-cardiovascular axis in patients with type 2 diabetes mellitus and non-alcoholic fatty liver disease. Effekt. Farmakoter. 2021;17(20):26-36. Russian. doi: https://doi.org/10.33978/2307-3586-2021-17-20-26-36
5. Chapman MJ, Ginsberg HN, Amarenco P, Andreotti F, Borén J, Catapano AL, Descamps OS, Fisher E, Kovanen PT, Kuivenhoven JA, Lesnik P, Masana L, Nordestgaard BG, Ray KK, Reiner Z, Taskinen MR, Tokgözoglu L, Tybjærg-Hansen A, Watts GF; European Atherosclerosis Society Consensus Panel. Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management. Eur. Heart J. 2011;32(11):1345-1361. doi: https://doi.org/10.1093/eurheartj/ehr112